Documents
Federal rules and notices from the public comment record, analyzed continuously.
DEA ▾
Revision of Applications for Manufacturing and Procurement Quotas NPRM
47 comments
Net support +43% across analyzed comments
Top issues in comments
- Medication shortage
- Data utilization for quota setting
- Medication quality
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
45 comments · 45 awaiting analysis
Analysis in progress
Top issues in comments
2026-09930
43 comments · 6 awaiting analysis
Net support -86% across analyzed comments
Top issues in comments
- Cultural preservation of traditional medicine
- Religious freedom
- Cultural and spiritual impact
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
2 comments
Net support 0% across analyzed comments
Top issues in comments
- Research barriers
2026-14704
1 comment
Net support -100% across analyzed comments
Top issues in comments
2026-13148
1 comment
Net support +100% across analyzed comments
Top issues in comments
2026-14286
1 comment
Net support -100% across analyzed comments
Top issues in comments
2026-11416
1 comment
Net support -100% across analyzed comments
Top issues in comments
- Harm reduction
2026-08586
1 comment
Net support +100% across analyzed comments
Top issues in comments
Schedules of Controlled Substances: Removal of Exemption Status for Inactive Butalbital Products
1 comment
Net support -100% across analyzed comments
Top issues in comments
- Methodology for identifying discontinued products
Designation of Phenethyl Halides as List I Chemicals
1 comment · 1 awaiting analysis
Analysis in progress
Top issues in comments
DEA-1442 DEA Letter to HHS 11012024
0 comments
Analysis in progress
Top issues in comments